Monoclonal antibody disposition: a simplified PBPK model and its implications for the derivation and interpretation of classical compartment models Ludivine FrontonSabine PilariWilhelm Huisinga Original Paper 04 February 2014 Pages: 87 - 107
Concordance between criteria for covariate model building Stefanie HennigMats O. Karlsson Original Paper 06 March 2014 Pages: 109 - 125
Preclinical PK/PD modeling and human efficacious dose projection for a glucokinase activator in the treatment of diabetes Michael G. ZagerKirk KozminskiShaoxian Sun Original Paper 28 February 2014 Pages: 127 - 139
Ubiquity: a framework for physiological/mechanism-based pharmacokinetic/pharmacodynamic model development and deployment John M. HarroldAnson K. Abraham Original Paper 12 March 2014 Pages: 141 - 151
Use of a linearization approximation facilitating stochastic model building Elin M. SvenssonMats O. Karlsson Original Paper Open access 13 March 2014 Pages: 153 - 158
Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 1: methotrexate Kayode OgungbenroLeon AaronsThe CRESim & Epi-CRESim Project Groups Original Paper 21 March 2014 Pages: 159 - 171
Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 2: 6-mercaptopurine and its interaction with methotrexate Kayode OgungbenroLeon AaronsThe CRESim & Epi-CRESim Project Groups Original Paper 21 March 2014 Pages: 173 - 185
Population pharmacokinetic analysis of fexofenadine in Japanese pediatric patients Jean-Marie MartinezSonia KhierDavid Fabre Original Paper 16 March 2014 Pages: 187 - 195